Godfrey Yew, the president and founder of Nutri Pharmaceuticals (Pink Sheets: NRPR), will be a featured guest on tomorrow night's airing of the Bill Chippas Show (Thursday June 8, 2006). This show airs at 6 p.m. EDT on AM radio channel 1590 (WPSL). Yew will specifically discuss Nutri Pharmaceutical's financial figures for 2005, and the strong preliminary results of the first five months of 2006. Nutri Pharmaceuticals Research Inc. (www.o2p.us) provides a wide range of powdered oils for functional food, food supplement, dietary supplement, cosmetics, pet food and animal feed applications. The company is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2P(TM) Powderization Process. At the heart of its oil powders is the O2P Oil-to-Powder technology. This patent-pending process converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P does not rely on traditional techniques that utilize extremes in heat or cold, or micro-encapsulation technology. The company currently offers more than 50 shelf-stable powders, many of which have a shelf life of two years. If you cannot listen to the broadcast live, or are outside the area for hearing the broadcast, the following link will permit you to hear a taping of the show. The link will have this featured show two hours after it has been broadcast: www.futurescom.com/billchippas-show.htm. Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the actual results of the company to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the company's reports and registration statements filed with the Securities and Exchange Commission.
Nutri Pharmaceuticals Re... (PK) (USOTC:NRPR)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Nutri Pharmaceuticals Re... (PK) 차트를 더 보려면 여기를 클릭.
Nutri Pharmaceuticals Re... (PK) (USOTC:NRPR)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Nutri Pharmaceuticals Re... (PK) 차트를 더 보려면 여기를 클릭.